Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: Effects on kidney function and transplantation outcomes

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-6473|21|11|1347-1354

ISSN： 1527-6465

Source： LIVER TRANSPLANTATION, Vol.21, Iss.11, 2015-11, pp. : 1347-1354

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 3, 2015-03 ,pp. : 300-307

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is type 2 hepatorenal syndrome still a potential indication for treatment with terlipressin and albumin?

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 11, 2015-11 ,pp. : 1335-1337

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liver, Pancreas and Kidney Transplantation for the Treatment of Wolcott–Rallison Syndrome

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 2, 2015-02 ,pp. : 565-567

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sirolimus-Based Immunosuppression in Kidney Transplantation for Type 2 Diabetic Nephropathy

By  

Urologia Internationalis, Vol. 84, Iss. 3, 2010-04 ,pp. : 301-304

Karger

Access to resources Recommend Favorite

Combined Liver–Kidney Transplantation for Primary Hyperoxaluria Type 2: A Case Report

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 18, Iss. 1, 2018-01 ,pp. : 253-257

John Wiley & Sons Inc

Access to resources Recommend Favorite